Andere Sprachen Dyadic International, Inc.

Aktien

A0JK0A

US26745T1016

DYAI

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 01.07.2024			% 5 Tage	% 1. Jan.
1,53 ^USD	+3,38 %		-3,77 %	-4,97 %

28.06.	Dyadic International, Inc. und Proliant Health and Biologicals geben Partnerschaft zur Entwicklung und Kommerzialisierung von rekombinantem Albumin bekannt	CI
14.05.	Transcript : Dyadic International, Inc., Q1 2024 Earnings Call, May 14, 2024

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Dyadic International, Inc. and Proliant Health and Biologicals announce Recombinant Albumin Development and Commercialization Partnership	01.07.
Dyadic Intl (NASDAQ: DYAI) and Proliant Health Biologicals to Launch $6 Billion Serum Albumin Market Product in 2025	01.07.
Dyadic International, Inc. and Proliant Health and Biologicals announce Recombinant Albumin Development and Commercialization Partnership	28.06.
Dyadic International, Inc. and Proliant Health and Biologicals Announce Recombinant Albumin Development and Commercialization Partnership	28.06.
Intelligent Bio Solutions Inc. (NASDAQ: INBS) Rises in After-Hours Trading Following Major UK Contracts and FDA Progress	27.06.
Kaival Brands Innovations Group (NASDAQ: KAVL) Secures $6M in Public Offering, Stock Surges Watch VTAK, OCGN, DYAI, INBS	27.06.
Peraso Inc. (NASDAQ: PRSO) Director Invests $127K, Ladenburg Thalmann Coverage, Gains Bullish Momentum	20.06.
Catheter Precision (NYSE American: VTAK) Announces New LockeT Purchase Order and Expands Sales Team Amid Surge in Trading Volume	19.06.
Peraso Inc. (NASDAQ: PRSO) Announces Paradigm-Shifting mmWave Wi-Fi Advancements with Phased Array Antenna Technology	06.06.
Dyadic to Attend Industry Events in June	30.05.
Dyadic International Inc. (DYAI): Bird Flu Vaccine Development Amid Rising Pandemic Concerns	30.05.
Dyadic International, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	14.05.
Earnings Flash (DYAI) DYADIC INTERNATIONAL Posts Q1 Revenue $334.6M	14.05.
Dyadic Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress	14.05.
Dyadic to Attend Industry and Investor Events in May	08.05.
Dyadic to Attend Industry and Investor Events in May	08.05.
Dyadic to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024	30.04.
Momentum Stocks Alert: DYAI, KAVL, VTAK, NKLA, ATAI Demonstrate Financial Growth and Strategic Advancements	08.04.
Dyadic International Inc. (NASDAQ: DYAI) Funding to Propel Near-Term Revenue Growth Initiatives Highlights in Zacks Small-Cap Research Report	04.04.
Dyadic International, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28.03.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Dyadic International, Inc.

Aktien

A0JK0A

US26745T1016

DYAI

Andere Sprachen

Filter